Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(8%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
25%
Ph phase_1
2
17%
Ph early_phase_1
1
8%
Ph phase_2
2
17%
Ph phase_4
2
17%
Ph phase_3
1
8%

Phase Distribution

3

Early Stage

2

Mid Stage

3

Late Stage

Phase Distribution11 total trials
Early Phase 1First-in-human
1(9.1%)
Phase 1Safety & dosage
2(18.2%)
Phase 2Efficacy & side effects
2(18.2%)
Phase 3Large-scale testing
1(9.1%)
Phase 4Post-market surveillance
2(18.2%)
N/ANon-phased studies
3(27.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

12

all time

Status Distribution
Active(2)
Completed(3)
Terminated(1)
Other(6)

Detailed Status

unknown6
Completed3
Recruiting1
Withdrawn1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (9.1%)
Phase 12 (18.2%)
Phase 22 (18.2%)
Phase 31 (9.1%)
Phase 42 (18.2%)
N/A3 (27.3%)

Trials by Status

unknown650%
completed325%
recruiting18%
withdrawn18%
not_yet_recruiting18%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
12